http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006047289-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8391016457f79ccf8bdf3e119f102f64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26ab91177aec52557a6b623996826856
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a56fd83402dff9a39c8374a49fece21
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-608
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
filingDate 2005-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f18599be3b3b9dffa60596cb81a613af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed4026cc25ef179df38f7fdd2ec1d67f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61a465aaf4cce2d35e1e7edaad5f7d60
publicationDate 2007-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006047289-A3
titleOfInvention Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function
abstract Medical devices with polymer coatings designed to control the release of angiotensin-(1-7) receptor agonist from medical devices are disclosed. The present application also discloses providing vascular stents with angiotesin-(1-7) receptor angonist-containing controlled-release coatings. Methods for treating or inhibiting post-stent implantation restenosis as well as improving vascular endothelial function in patients are also provided.
priorityDate 2004-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005069966-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03079936-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006047378-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006049490-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6235766-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1258258-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03072059-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03090807-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9964585-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46878481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555446

Total number of triples: 36.